Human Pathology
Volume 37, Issue 3 , Pages 352-360 , March 2006

Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis

  • Pinak S. Acharya, MD

      Affiliations

    • Department of Medicine, Division of Pulmonary, Allergy and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    • The Wistar Institute, Philadelphia, PA 19104-4268, USA
    • Corresponding Author InformationCorresponding author. The Wistar Institute, Philadelphia, PA 19104-4268, USA.
    • ,
  • Alicia Zukas

      Affiliations

    • The Wistar Institute, Philadelphia, PA 19104-4268, USA
    • ,
  • Vishal Chandan, MD

      Affiliations

    • Department of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    • ,
  • Anna-Luise A. Katzenstein, MD

      Affiliations

    • Department of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    • ,
  • Ellen Puré, PhD

      Affiliations

    • Department of Medicine, Division of Pulmonary, Allergy and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    • The Wistar Institute, Philadelphia, PA 19104-4268, USA
    • The Ludwig Institute for Cancer Research, New York, NY 10158, USA

Received 25 August 2005 ,Revised 17 November 2005 ,Accepted 21 November 2005.

References 

  1. Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathological classification. Am J Respir Crit Care Med. 1998;157:1301–1315
  2. Elias JA, Zitnik RJ, Ray P. Fibroblast immune-effector function. In:  Phipps RP editors. Pulmonary fibroblast heterogeneity. Boca Raton: CRC Press; 1992;p. 295–322
  3. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-b1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103
  4. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999;250:273–283
  5. Levy MT, McCauhan GW, Marinos G, Gorrell MD. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver. 2002;22:93–101
  6. Rubbia-brandt L, Mentha G, Desmouliere A, et al. Hepatic stellate cells reversibly express alpha-smooth muscle actin during acute hepatic ischaemia. Transplant Proc. 1997;29:2390–2395
  7. Zhang HY, Gharaee-Kermani M, Zhang K, Karmiol S, Phan SH. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1996;148:527–537
  8. Fukuda Y, Basset F, Ferrans VJ, Yamanaka N. Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis. Hum Pathol. 1995;26:53–61
  9. Rettig WJ, Su SL, Fortunato SR, et al. Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer. 1994;58:385–392
  10. Scanlan MJ, Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A. 1994;91:5657–5661
  11. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165:277–304
  12. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274:36505–36512
  13. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136–151
  14. Estes JM, Vande Berg JS, Adzick NS, MacGillivray TE, Desmouliere A, Gabbiani G. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation. 1994;56:173–181
  15. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol. 1994;145:114–125
  16. Sappino A, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulation. Lab Invest. 1990;63:144–161
  17. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538–549
  18. Levy MT, McCaughan GW, Abbott CA, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodeling interface in human cirrhosis. Hepatology. 1999;29:1768–1778
  19. Rettig WJ, Garin-Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ. Cell surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A. 1988;85:3110–3114
  20. Niedermeyer J, Scanlan MJ, Garin-Chesa P, et al. Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int J Cancer. 1997;71:383–389
  21. Rettig WJ, Garin-Chesa P, Healey JH, et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 1993;53:3327–3335
  22. Proost P, De Meester I, Schols D, et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem. 1998;273:7222–7227
  23. De Meester I, Durinx C, Bal G, et al. Natural substrates of dipeptidyl peptidase IV. Adv Exp Med Biol. 2000;477:67–87
  24. Wesley UV, Albino AP, Tiwari S, Houghton AN. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med. 1999;190:311–322
  25. Ghersi G, Dong H, Goldstein LA, et al. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem. 2002;277:29231–29241
  26. Kapanci Y, Desmouliere A, Pache JC, Redard M, Gabbiani G. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. Am J Respir Crit Care Med. 1995;152:2163–2169
  27. Khalil N, O'Connor RN, Flanders KC, Unruh H. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol. 1996;14:131–138
  28. Adamson IY, Hedgecock C, Bowden DH. Epithelial cell–fibroblast interactions in lung injury and repair. Am J Pathol. 1990;137:385–392
  29. Uhal BD, Joshi I, True AL, et al. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol. 1995;269:L819–L828
  30. Barbas-Filho JV, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, Capelozzi VL. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol. 2001;54:132–138
  31. Adams S, Miller GT, Jesson MI, Watanabe T, Jones B, Wallner BP. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 2004;64:5471–5480
  32. Jelaska A, Strehlow D, Korn JH. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol. 1999;21:385–395
  33. Brown DD, Wang Z, Furlow JD, et al. The thyroid hormone–induced tail resorption program during Xenopus laevis metamorphosis. Proc Natl Acad Sci U S A. 1996;93:1924–1929
  34. Roberts AB, Sporn MB. Transforming growth factor β. In:  Clark RAF editors. The molecular cell biology of wound repair. New York: Plenum Press; 1996;p. 275–308
  35. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol. 2003;162:533–546

☆ This study was supported by PHS grant P50-HL67663 and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health.

PII: S0046-8177(05)00690-8

doi: 10.1016/j.humpath.2005.11.020

Human Pathology
Volume 37, Issue 3 , Pages 352-360 , March 2006

Article Tools

* Image Usage & Resolution